長期投資家のためのIR情報
バリュートレンド

【5187】クリエートメディック
使い捨て医療器具。シリコン製カテーテル等。
類似企業:
【業界1位】 テルモ
【売上同水準】 メディキット 北里


東証スタンダード
精密
>
医器
売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 日付 予・実 売上高
(百万円)
対前回 修正率 修正率 営業利益
(百万円)
対前回 修正率 修正率 経常利益
(百万円)
対前回 修正率 修正率 当期利益
(百万円)
対前回 修正率 修正率
2026.12 2026/08/05 Q2予 13,960 → 0.0% 0.0% 760 ↓ -28.3% -28.3% 800 ↓ -25.2% -25.2% 560 ↓ -25.3% -25.3%
2026.12 2026/05/07 Q1予 13,960 → 0.0% 0.0% 1,060 → 0.0% 0.0% 1,070 → 0.0% 0.0% 750 → 0.0% 0.0%
2026.12 2026/02/13 当初予 13,960 - - - 1,060 - - - 1,070 - - - 750 - - -
2025.12 2026/02/13 実 13,617 ↑ +0.3% +0.3% 1,005 ↑ +0.3% +0.3% 988 ↓ -5.3% -5.3% 713 ↓ -10.4% -10.4%
2025.12 2025/10/31 Q3予 13,583 → 0.0% 0.0% 1,002 → 0.0% 0.0% 1,043 → 0.0% 0.0% 796 → 0.0% 0.0%
2025.12 2025/08/05 Q2予 13,583 → 0.0% 0.0% 1,002 → 0.0% 0.0% 1,043 → 0.0% 0.0% 796 → 0.0% 0.0%
2025.12 2025/05/07 Q1予 13,583 → 0.0% 0.0% 1,002 → 0.0% 0.0% 1,043 → 0.0% 0.0% 796 → 0.0% 0.0%
2025.12 2025/02/13 当初予 13,583 - - - 1,002 - - - 1,043 - - - 796 - - -
2024.12 2025/02/13 実 13,030 ↓ -0.0% -0.0% 692 ↓ -20.3% -20.3% 750 ↓ -16.7% -16.7% 840 ↓ -13.1% -13.1%
2024.12 2024/10/31 Q3予 13,032 → 0.0% 0.0% 868 → 0.0% 0.0% 900 → 0.0% 0.0% 967 → 0.0% 0.0%
2024.12 2024/08/05 Q2予 13,032 → 0.0% 0.0% 868 → 0.0% 0.0% 900 → 0.0% 0.0% 967 → 0.0% 0.0%
2024.12 2024/05/07 Q1予 13,032 → 0.0% 0.0% 868 → 0.0% 0.0% 900 → 0.0% 0.0% 967 → 0.0% 0.0%
2024.12 2024/02/14 当初予 13,032 - - - 868 - - - 900 - - - 967 - - -
2023.12 2024/02/14 実 12,585 ↑ +0.2% +0.4% 803 ↑ +15.5% -9.3% 872 ↑ +13.2% -3.3% 154 ↑ +294.9% -73.9%
2023.12 2023/10/31 Q3予 12,556 ↑ +0.2% +0.2% 695 ↓ -21.5% -21.5% 770 ↓ -14.6% -14.6% 39 ↓ -93.4% -93.4%
2023.12 2023/08/04 Q2予 12,537 → 0.0% 0.0% 885 → 0.0% 0.0% 902 → 0.0% 0.0% 591 → 0.0% 0.0%
2023.12 2023/05/08 Q1予 12,537 → 0.0% 0.0% 885 → 0.0% 0.0% 902 → 0.0% 0.0% 591 → 0.0% 0.0%
2023.12 2023/02/13 当初予 12,537 - - - 885 - - - 902 - - - 591 - - -
2022.12 2023/02/13 実 12,257 ↑ +3.9% +3.9% 737 ↓ -16.3% -16.3% 809 ↓ -10.1% -10.1% 460 ↓ -27.9% -27.9%
2022.12 2022/10/31 Q3予 11,802 → 0.0% 0.0% 881 → 0.0% 0.0% 900 → 0.0% 0.0% 638 → 0.0% 0.0%
2022.12 2022/08/04 Q2予 11,802 → 0.0% 0.0% 881 → 0.0% 0.0% 900 → 0.0% 0.0% 638 → 0.0% 0.0%
2022.12 2022/05/06 Q1予 11,802 → 0.0% 0.0% 881 → 0.0% 0.0% 900 → 0.0% 0.0% 638 → 0.0% 0.0%
2022.12 2022/02/10 当初予 11,802 - - - 881 - - - 900 - - - 638 - - -
2021.12 2022/02/10 実 11,698 ↑ +1.2% +5.5% 866 ↓ -14.7% +9.9% 1,009 ↓ -5.8% +26.1% 660 ↓ -5.8% +18.1%
2021.12 2021/10/28 Q3予 11,556 ↑ +4.2% +4.2% 1,015 ↑ +28.8% +28.8% 1,071 ↑ +33.9% +33.9% 701 ↑ +25.4% +25.4%
2021.12 2021/08/04 Q2予 11,086 → 0.0% 0.0% 788 → 0.0% 0.0% 800 → 0.0% 0.0% 559 → 0.0% 0.0%
2021.12 2021/05/06 Q1予 11,086 → 0.0% 0.0% 788 → 0.0% 0.0% 800 → 0.0% 0.0% 559 → 0.0% 0.0%
2021.12 2021/02/10 当初予 11,086 - - - 788 - - - 800 - - - 559 - - -
2020.12 2021/02/10 実 10,830 ↓ -2.8% -2.8% 984 ↓ -9.7% -9.7% 952 ↓ -13.5% -13.5% 659 ↓ -12.1% -12.1%
2020.12 2020/02/12 当初予 11,140 - - - 1,090 - - - 1,100 - - - 750 - - -
2019.12 2020/02/12 実 10,843 ↓ -0.8% -0.8% 1,083 ↑ +8.3% +8.3% 1,065 ↑ +5.4% +5.4% 725 ↑ +3.6% +3.6%
2019.12 2019/10/30 Q3予 10,930 → 0.0% 0.0% 1,000 → 0.0% 0.0% 1,010 → 0.0% 0.0% 700 → 0.0% 0.0%
2019.12 2019/08/01 Q2予 10,930 → 0.0% 0.0% 1,000 → 0.0% 0.0% 1,010 → 0.0% 0.0% 700 → 0.0% 0.0%
2019.12 2019/05/07 Q1予 10,930 → 0.0% 0.0% 1,000 → 0.0% 0.0% 1,010 → 0.0% 0.0% 700 → 0.0% 0.0%
2019.12 2019/02/13 当初予 10,930 - - - 1,000 - - - 1,010 - - - 700 - - -
2018.12 2019/02/13 実 10,796 ↑ +0.4% +1.3% 993 ↑ +6.2% +10.3% 999 ↑ +5.2% +7.4% 672 ↑ +0.3% +6.5%
2018.12 2018/10/30 Q3予 10,750 → 0.0% +0.9% 935 → 0.0% +3.9% 950 → 0.0% +2.2% 670 → 0.0% +6.2%
2018.12 2018/08/02 Q2予 10,750 ↑ +0.9% +0.9% 935 ↑ +3.9% +3.9% 950 ↑ +2.2% +2.2% 670 ↑ +6.2% +6.2%
2018.12 2018/05/02 Q1予 10,656 → 0.0% 0.0% - - - - 930 → 0.0% 0.0% 631 → 0.0% 0.0%
2018.12 2018/02/13 当初予 10,656 - - - 900 - - - 930 - - - 631 - - -
2017.12 2018/02/13 実 10,393 ↑ +2.4% +3.7% 854 ↑ +1.7% +33.2% 880 ↑ +3.5% +34.4% 467 ↓ -15.1% +10.7%
2017.12 2017/10/30 Q3予 10,150 → 0.0% +1.3% 840 → 0.0% +31.0% 850 → 0.0% +29.8% 550 → 0.0% +30.3%
2017.12 2017/08/03 Q2予 10,150 ↑ +1.3% +1.3% 840 ↑ +31.0% +31.0% 850 ↑ +29.8% +29.8% 550 ↑ +30.3% +30.3%
2017.12 2017/05/02 Q1予 10,023 → 0.0% 0.0% 641 → 0.0% 0.0% 655 → 0.0% 0.0% 422 → 0.0% 0.0%
2017.12 2017/02/13 当初予 10,023 - - - 641 - - - 655 - - - 422 - - -
2016.12 2017/02/13 実 10,003 ↑ +2.4% +2.4% 754 ↑ +6.8% +110.0% 821 ↑ +35.0% +121.9% 516 ↑ +20.0% +129.3%
2016.12 2016/10/31 Q3予 9,768 → 0.0% 0.0% 706 → 0.0% +96.7% 608 → 0.0% +64.3% 430 → 0.0% +91.1%
2016.12 2016/08/04 Q2予 9,768 → 0.0% 0.0% 706 ↑ +96.7% +96.7% 608 ↑ +64.3% +64.3% 430 ↑ +91.1% +91.1%
2016.12 2016/02/12 当初予 9,768 - - - 359 - - - 370 - - - 225 - - -
2015.12 2016/02/12 実 9,650 → 0.0% -7.6% 648 ↑ +4.5% -23.8% 654 ↑ +0.6% -24.0% 333 ↑ +1.8% -41.5%
2015.12 2015/10/30 Q3予 9,650 → 0.0% -7.6% 620 → 0.0% -27.1% 650 → 0.0% -24.5% 327 → 0.0% -42.5%
2015.12 2015/08/04 Q2予 9,650 ↓ -7.6% -7.6% 620 ↓ -27.1% -27.1% 650 ↓ -24.5% -24.5% 327 ↓ -42.5% -42.5%
2015.12 2015/05/01 Q1予 10,445 → 0.0% 0.0% 850 → 0.0% 0.0% 861 → 0.0% 0.0% 569 → 0.0% 0.0%
2015.12 2015/02/12 当初予 10,445 - - - 850 - - - 861 - - - 569 - - -
2014.12 2015/02/12 実 9,939 ↓ -1.8% -1.8% 784 ↓ -16.0% -16.0% 1,002 ↑ +7.7% +7.7% 490 ↓ -20.3% -20.3%
2014.12 2014/11/04 Q3予 10,124 → 0.0% 0.0% 933 → 0.0% 0.0% 930 → 0.0% 0.0% 615 → 0.0% 0.0%
2014.12 2014/08/06 Q2予 10,124 → 0.0% 0.0% 933 → 0.0% 0.0% 930 → 0.0% 0.0% 615 → 0.0% 0.0%
2014.12 2014/05/02 Q1予 10,124 → 0.0% 0.0% 933 → 0.0% 0.0% 930 → 0.0% 0.0% 615 → 0.0% 0.0%
2014.12 2014/02/12 当初予 10,124 - - - 933 - - - 930 - - - 615 - - -
2013.12 2014/02/12 実 9,880 - - - 824 - - - 953 - - - 533 - - -
シェア ツイート
ページトップへ戻る